Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,942,902
-
Share change
-
-754,976
-
Total reported value
-
$6,082,053
-
Price per share
-
$0.30
-
Number of holders
-
48
-
Value change
-
-$496,460
-
Number of buys
-
12
-
Number of sells
-
36
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q3 2023
As of 30 Sep 2023,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,942,902 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, Simplify Asset Management Inc., 683 Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., UBS OCONNOR LLC, RBF Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, and MILLENNIUM MANAGEMENT LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.